Status: Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
This study will test an experimental drug called KQB198 in combination with imatinib. The goal is to determine if this combination is safe and tolerable and assess how effective the combination is at treating GIST. Imatinib has been approved by the FDA for the treatment of different types of cancer including GIST.
Participants needed: 46
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Kumquat Biosciences Inc.Updated: May 19, 2026Locations: 8
Eligibility criteria
Unresectable or metastatic disease [+5]
Unable to swallow or GI condition that prevents absorption. [+2]